James Chevalier

Other News

On “Endpoints Clinical Trials Day,” Lupus Therapeutics EVP Expresses Optimism About the Current State of Lupus Research

December 17, 2024

Today is “Endpoints Clinical Trials Day,” hosted by international biopharma news outlet Endpoints News. The day features a series...

Request for Applications: see article for details

Lupus Therapeutics Announces a New, Groundbreaking Mechanism to Fund Clinical Studies Addressing the Impact of Diet, Nutrition, and Microbiome on Lupus

November 22, 2024

The unique IDEAL (Investigate Dietary Approaches for Lupus) Initiative will provide multidisciplinary research teams the opportunity to conduct innovative and...

LRA Spotlight on ACR Convergence 2024: Lupus Therapeutics-Supported Clinical Research and More

November 21, 2024

New ACR guidelines for advancing the management of lupus nephritis (LN). Novel approaches and promising data from early- to...